サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1114099

多血小板血漿の市場規模、シェア、動向分析レポートタイプ別（純粋血小板豊富血漿、白血球豊富血漿）、用途別（整形外科、スポーツ医学、美容外科）、最終用途別、地域別、そしてセグメント別予測、2022年～2030年

Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type (Pure Platelet Rich Plasma, Leukocyte Rich), By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
多血小板血漿の市場規模、シェア、動向分析レポートタイプ別（純粋血小板豊富血漿、白血球豊富血漿）、用途別（整形外科、スポーツ医学、美容外科）、最終用途別、地域別、そしてセグメント別予測、2022年～2030年
出版日: 2022年07月22日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多血小板血漿市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の多血小板血漿の市場規模は、2022年から2030年にかけて15.11%のCAGRを記録し、2030年までに19億4000万米ドルに達すると予測されています。

美容外科手術の増加、国内外のスポーツイベントの増加、血漿ベースの治療法における研究の拡大が、業界の成長を後押ししています。さらに、血小板リッチ血漿（PRP）ベースの治療法の研究開発活動や規制当局の承認は、主要な市場促進要因となっています。

現在、スポーツ傷害、整形外科疾患、筋骨格系疾患の治療におけるPRPの使用に対する需要が急増しています。PRPは、成長因子を集中的に投与し、治癒に要する時間を大幅に短縮することができます。PRPはまた、再生医療分野での主要なアプリケーションを見つけ、創傷治癒と修復カスケードをスピードアップする各患者のためのカスタム製品として機能します。

多血小板血漿は、形成外科において、体自身の自然な組織修復プロセスを利用し、形と機能の改善を達成するために有望な結果を得て発展してきました。使いやすく、患者の細胞を利用して安価に製造でき、副作用のリスクがほとんどないといった特徴が、PRP療法によって提供される主な利点です。しかし、治療には時間がかかり、複数回のセッションが必要でした。また、肌の若返り、肌の色素沈着、にきび跡の治療、ヴァンパイアフェイシャルでの肌の引き締めなどに効果があります。PRPは、毛包の形成と維持に役立つ植毛用のサプリメントとして使用されています。このように、多血小板血漿の広範な用途は、業界の成長を促進すると予想されます。

さらに、主なプレイヤーは、市場に参入するために、M&A、製品開発、事業拡大などの戦略的イニシアチブを実施しています。2021年9月、テルモBCTは、米国での顧客基盤の拡大を視野に、カルタゴのラ・リマに新しい製造施設を開設し、コスタリカでのプレゼンスを拡大しました。 2020年2月、EmCyte株式会社は、Centrepid platelet concentrator systemを有するCellmedix Holdings LLCを取得しました。これにより、同社の製品ポートフォリオが拡大し、市場での存在感が向上しました。

COVID-19に照らし合わせると、サプライチェーンの混乱、リソース配分の制約、患者アクセス活動の妨げなどの理由で、市場は大きな後退を経験しました。しかし、2021年1月までに市場は安定化し、需要と供給の正常化を続け、ユーザーと患者は血小板リッチ血漿へのアクセスを取り戻しました。

多血小板血漿市場レポートハイライト

タイプ別では、純粋な多血小板血漿セグメントが、様々な治療領域で広く使用され、世界中で適応外使用に対する需要が高まっていることから、2021年に50.0%を超える最大の収益シェアを占めました。

用途別では、整形外科における様々な用途でPRPを調査する研究数が急増していることから、整形外科セグメントが2021年に市場を独占しました。しかし、皮膚科、スポーツ医学、潰瘍治癒などの他のセグメントは、予測期間中により速い速度で成長すると予想される

病院の最終用途セグメントは、2021年に最大の収益シェアを占めました。これは、PRPベースの治療を提供する病院数の増加や、近年の変形性膝関節症の症例数の増加によるものであると考えられます

北米は、RPPの幅広い用途、PRPベースの治療法に関する認知度の上昇、整形外科疾患の発生件数の増加により、2021年の世界市場を独占しました。

アジア太平洋地域は、美容整形手術の増加や医療観光産業の成長により、将来的に大きく成長すると予想されています。

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査の仮定
    • 推定・予測のタイムライン
  • 情報調達
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査内容
  • 情報またはデータ分析
    • 多血小板血漿（PRP）市場：セグメントの収益と成長分析
    • スポーツ医学市場：セグメントの収益と成長分析
    • 多血小板血漿（PRP）ベースの潰瘍治癒市場：セグメントの収益と成長分析
      • 多血小板血漿（PRP）ベースの潰瘍治癒市場：セグメントの定義
      • 非治癒性潰瘍
      • 糖尿病性潰瘍
      • 褥瘡
      • 壊疽性膿皮症
      • 静脈潰瘍
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
      • アプローチ1：コモディティフローアプローチ
      • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
  • 市場：CAGR計算
  • 二次情報一覧
  • 一次情報のリスト
  • 目的

第2章 市場の定義

第3章 エグゼクティブサマリー

  • 市場の見通し
  • 市場概要

第4章 宿主細胞汚染物質検査市場の変数、動向、範囲

  • 市場動向と展望
  • 市場セグメンテーションと範囲
  • 市場促進要因分析
    • 整形外科疾患とスポーツ外傷の発生率の上昇
    • 宿主細胞の汚染検出に対する規制強化
    • 多血小板血漿の医療応用の拡大
    • PRPベースの創傷治癒に関するエビデンスに基づく研究の増加
  • 市場制約分析
    • PRP製品に関連する高コスト
  • 要因別SWOT分析（政治と法律、経済、技術）
  • ポーターのファイブフォース分析
  • COVID-19影響分析
  • 浸透と成長の見通しのマッピング

第5章 多血小板血漿市場-セグメント分析、タイプ別、2018年から2030年（百万米ドル）

  • 多血小板血漿市場：型の変動分析
  • ピュア PRP
  • 白血球リッチPrp
  • その他

第6章 多血小板血漿市場-セグメント分析、アプリケーション別、2018年から2030年（100万米ドル）

  • 多血小板血漿：アプリケーションの変動分析
  • 整形外科
  • スポーツ医学
  • 美容整形
  • 皮膚科
    • 対象シナリオ：米国のメディケアおよびメディケイドサービスセンター
    • 潰瘍治癒
      • 静脈潰瘍
      • 外傷性潰瘍
      • 壊疽性膿皮症潰瘍
      • 糖尿病性潰瘍
      • 栄養性潰瘍
      • 血管炎性潰瘍
    • その他
  • 眼科外科
  • 脳神経外科
  • 一般外科
  • その他

第7章 多血小板血漿（PRP）市場-セグメント分析、最終用途別、2018年から2030年（百万米ドル）

  • 多血小板血漿（PRP）：エンドユース変動分析
  • 病院
  • 診療所
  • その他

第8章 多血小板血漿（PRP）市場- セグメント分析、地域別、2018年から2030年（100万米ドル）

  • 多血小板血漿（PRP）市場：地域変動分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • スペイン
    • フランス
    • イタリア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東とアフリカ
    • 南アフリカ
    • アラブ首長国連邦
    • サウジアラビア

第9章 企業プロファイル

  • 戦略的枠組み
  • 市場参加の分類
  • 企業プロファイル
    • Johnson &Johnson
      • 会社概要
      • DePuy合成
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Arthrex, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • EmCyte Corporation
      • 会社概要
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • DR. PRP AMERICA, LLC
      • 会社概要
      • 製品のベンチマーク
    • Juventix
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
    • Terumo Corporation
      • 会社概要
      • テルモBCT株式会社
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Zimmer Biomet
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Stryker
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Apex Biologix
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Celling Biosciences
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19 U.K. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 U.K. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 U.K. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 44 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 47 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 54 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 60 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 75 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 PRP segment revenue modeling
  • Fig. 5 Sports medicine market segment revenue modeling
  • Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
  • Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
  • Fig. 8 Market research approaches
  • Fig. 9 Value chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Platelet rich plasma (PRP) market snapshot, 2021 (USD Million)
  • Fig. 13 Platelet rich plasma (PRP) market segmentation
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
  • Fig. 16 Incidence of arthritis in U.S., by age
  • Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
  • Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
  • Fig. 19 Common cosmetic surgical procedures in 2019
  • Fig. 20 Cosmetic plastic demographic data in 2019
  • Fig. 21 Common minimal invasive procedures in 2019, U.S.
  • Fig. 22 Number of customers for cosmetic surgery in China (Million)
  • Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
  • Fig. 24 Market restraint relevance analysis (Current & future impact)
  • Fig. 25 Market opportunity relevance analysis (Current & future impact)
  • Fig. 26 Penetration and growth prospect mapping, by Application, 2021
  • Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
  • Fig. 28 Platelet rich plasma (PRP) market Porter's five forces analysis
  • Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
  • Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
  • Fig. 31 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
  • Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
  • Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
  • Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
  • Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
  • Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
  • Fig. 42 Categorization of studies based on types of ulcers
  • Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
  • Fig. 44 Meta-analysis of lower extremity venous ulcers
  • Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
  • Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
  • Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
  • Fig. 48 Results obtained for individuals treated with PRP-Part A
  • Fig. 49 Results obtained for individuals treated with PRP-Part B
  • Fig. 50 Results obtained for individuals treated with PRP-Part C
  • Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
  • Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
  • Fig. 53 Reduction in the surface area of trophic ulcers
  • Fig. 54 Reduction in the surface area of trophic ulcers
  • Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
  • Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
  • Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
  • Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
  • Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
  • Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
  • Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
  • Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
  • Fig. 66 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
  • Fig. 67 Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
  • Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
  • Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
  • Fig. 70 Strategy framework
  • Fig. 71 Market participation categorization
目次
Product Code: GVR-1-68038-869-5

Platelet Rich Plasma Market Growth & Trends:

The global platelet rich plasma market size is expected to reach USD 1.94 billion by 2030, registering a CAGR of 15.11% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.

Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.

Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body's own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient's cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.

Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company's product portfolio and improved its market presence.

In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2021, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.

Platelet Rich Plasma Market Report Highlights:

  • By type, the pure platelet-rich plasma segment held the largest revenue share of over 50.0% in 2021 due to its widespread use across various therapeutic areas and rising demand for its off-label uses worldwide
  • By application, the orthopedics segment dominated the market in 2021 due to an upsurge in the number of research studies to investigate PRP across various applications in orthopedics. However, other segments such as dermatology, sports medicine, and ulcer healing are expected to grow at a faster rate over the forecast period
  • The hospitals end-use segment held the largest revenue share in 2021. This can be attributed to an increase in the number of hospitals delivering PRP-based therapies and rising number of knee osteoarthritis cases in recent years
  • North America dominated the global market in 2021 due to wider applications of RPP, rising awareness about PRP-based treatments, and increasing number of orthopedics incidences
  • Asia Pacific is expected to grow considerably in the future owing to rising number of cosmetic surgeries and growing medical tourism industry

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Information Procurement
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
    • 1.6.2 sports medicine market: segment revenue and growth analysis
    • 1.6.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
      • 1.6.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
      • 1.6.3.1.1 Non-Healing Ulcers
      • 1.6.3.1.1.1 Diabetic Ulcers
      • 1.6.3.1.1.2 Pressure Ulcers
      • 1.6.3.1.1.3 Pyoderma gangrenosum
      • 1.6.3.1.1.4 Venous ulcers
    • 1.6.4 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.9 Market: CAGR Calculation
  • 1.10 List of Secondary Sources
  • 1.11 List of Primary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Market Summary

Chapter 4 Host Cell Contaminant Testing Market Variables, Trends & Scope

  • 4.1 Market Trends & Outlook
  • 4.2 Market Segmentation & Scope
  • 4.3 Market Driver Analysis
    • 4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
    • 4.3.2 Increasing Regulatory Focus On Host Cell Contaminant Detection
    • 4.3.3 extending Medical Applications Of Platelet Rich Plasma
    • 4.3.4 Increasing Number Of Evidence-Based Studies For Prp-Based Wound Healing
  • 4.4 Market Restraint Analysis
    • 4.4.1 high Costs Associated With Prp Products
  • 4.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 4.6 Porter's Five Forces Analysis
  • 4.7 COVID-19 Impact Analysis
  • 4.8 Penetration & Growth Prospect Mapping

Chapter 5 Platelet Rich Plasma Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1 Platelet Rich PlasmaMarket: Type Movement Analysis
  • 5.2 Pure PRP
    • 5.2.1 Pure Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 leukocyte Rich Prp
    • 5.3.1 leukocyte Rich Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Other Type Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Platelet Rich Plasma market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 platelet Rich Plasmamarket: Application Movement Analysis
  • 6.2 Orthopedics
    • 6.2.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Sports Medicine
    • 6.3.1 Sport Medicine market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Cosmetic Surgery
    • 6.4.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Cosmetic Surgery, 2018 - 2030
  • 6.5 Dermatology
    • 6.5.1 Coverage Scenario: U.S. Centers For Medicare & Medicaid Services
    • 6.5.2 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Dermatology, 2018 - 2030
    • 6.5.3 Ulcer healing
      • 6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 - 2030
      • 6.5.3.2 Venous ulcers
      • 6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 - 2030
      • 6.5.3.3 Traumatic ulcers
      • 6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 - 2030
      • 6.5.3.4 Pyoderma gangrenosum ulcers
      • 6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030
      • 6.5.3.5 Diabetic ulcers
      • 6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 - 2030
      • 6.5.3.6 Trophic ulcers
      • 6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 - 2030
      • 6.5.3.7 Vasculitic ulcers
      • 6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030
    • 6.5.4 Others
      • 6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 - 2030
  • 6.6 Ophthalmic Surgery
    • 6.6.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Ophthalmic Surgery, 2018 - 2030
  • 6.7 Neurosurgery
    • 6.7.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Neurosurgery, 2018 - 2030
  • 6.8 General Surgery
    • 6.8.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For General Surgery, 2018 - 2030
  • 6.9 Others
    • 6.9.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Others, 2018 - 2030

Chapter 7 Platelet Rich Plasma (PRP) Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

  • 7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospitals market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Clinics
    • 7.3.1 Clinics market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Platelet Rich Plasma (PRP) Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 UAE
      • 8.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Saudi Arabia
      • 8.6.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Company Profile

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Johnson & Johnson
      • 9.3.1.1 Company overview
      • 9.3.1.2 DePuy Synthes
      • 9.3.1.2.1 Company overview
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product benchmarking
      • 9.3.1.5 Strategic initiatives
    • 9.3.2 Arthrex, Inc.
      • 9.3.2.1 Company overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product benchmarking
      • 9.3.2.4 Strategic initiatives
    • 9.3.3 EmCyte Corporation
      • 9.3.3.1 Company overview
      • 9.3.3.2 Product benchmarking
      • 9.3.3.3 Strategic initiatives
    • 9.3.4 DR. PRP AMERICA, LLC
      • 9.3.4.1 Company overview
      • 9.3.4.2 Product benchmarking
    • 9.3.5 Juventix
      • 9.3.5.1 Company overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product benchmarking
    • 9.3.6 Terumo Corporation
      • 9.3.6.1 Company overview
      • 9.3.6.2 TERUMO BCT, INC.
      • 9.3.6.2.1 Company overview
      • 9.3.6.3 Financial Performance
      • 9.3.6.4 Product benchmarking
      • 9.3.6.5 Strategic initiatives
    • 9.3.7 Zimmer Biomet
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product benchmarking
      • 9.3.7.4 Strategic initiatives
    • 9.3.8 Stryker
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 Apex Biologix
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Celling Biosciences
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives